A. Hofstetter Olsson
Are you A. Hofstetter Olsson?
Claim your profile
Treating breathing disorder e.g. apnea, in mammalian subject, comprises administering composition comprising E-prostanoid receptor subtype 3 inhibitor, microsomal prostaglandin E synthase-1 inhibitor and/or cyclooxygenase-2 inhibitor
, A. Hofstetter Olsson,
Ref. No: 2009-J57191, Year: 01/2008
Browse more researchers
© 2013 researchgate.net. All rights reserved.
Already a member?
Keep me logged in
ResearchGate is the professional network for scientists and researchers. Join today, it's free!
Sign Up »